Author:
Withanarachchie Vinuli,Rychert Marta,Wilkins Chris
Abstract
Abstract
Background
Privately-owned cannabis clinics have sprung up in many jurisdictions where medicinal cannabis has been legalised and provide an alternative pathway for patients who are unable or unwilling to access a prescription for cannabis-based medicinal products from their usual healthcare providers.
Aims
This study aimed to explore physicians’ views on cannabis clinics, including their perceptions of the role cannabis clinics play in the wider health system.
Methods
A qualitative study using in-depth, semi-structured interviews with thirty-one physicians affiliated with private and community clinics in New Zealand (including cannabis clinicians, GPs, and specialist doctors). The interviews were conducted from July to December 2021. Data were transcribed and analysed using inductive thematic analysis.
Results
Cannabis clinicians positioned themselves as (1) “service providers”, facilitating consumer access to cannabis prescriptions and products, and (2) “educators”, providing advice to patients and the wider physician community. While general practitioners and specialists recognised the benefits of specialised cannabis clinics (i.e., knowledge of products and a non-judgmental environment), they questioned the limited evidence of clinical efficacy for cannabis, potential financial conflicts of interests of cannabis clinicians that may blur their clinical judgement, and the risk of compartmentalising patients’ healthcare.
Conclusions
Our paper raises a number of challenges with attempting to integrate cannabis clinics into the wider health system.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Aguilar B S, Gutiérrez V, Sánchez L, Nougier M. Medicinal cannabis policies and practices around the world: International Drug Policy Consortium, 2018, April. (Briefing paper). http://fileserver.idpc.net/library/Medicinal%20cannabis%20briefing_ENG_FINAL.PDF.
2. Sznitman SR, Bretteville-Jensen AL. Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies. Harm Reduct J. 2015;12:46. https://doi.org/10.1186/s12954-015-0082-x.
3. Schlag A. An evaluation of regulatory regimes of medical Cannabis: what lessons can be learned for the UK? Med Cannabis Cannabinoids. 2020;3:1–8. https://doi.org/10.1159/000505028.
4. Department of Cannabis Control. California’s cannabis laws. 2021. Retrieved December 9, 2021 from https://cannabis.ca.gov/resources/laws-and-regulations/.
5. National Health System. Cannabis-based products for medicinal use: Frequently asked questions. no date. Retrieved February 6, 2021 from https://www.england.nhs.uk/medicines-2/support-for-prescribers/cannabis-based-products-for-medicinal-use/cannabis-based-products-for-medicinal-use-frequently-asked-questions/#who-can-prescribe-a-cannabis-based-product-for-medicinal-use.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献